Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
about
A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface AntigenEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaoundé, Cameroon: An Appeal for Revised Policies in Tropical Settings?Factors influencing immunologic response to hepatitis B vaccine in adultsPredictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.Overseas Hepatitis B Vaccinations Among Newly Arrived Cubans in Texas-2010-2015.No longer 'written off' - times have changed for the BBV-infected dental professional.Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.Achieving protection against HBV in HIV patients: Finding the best strategy.Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014.Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months.Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program.Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.From Infancy and Beyond… Ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.Decline in hepatitis B and C prevalence among hemodialysis patients in Tocantins, Northern BrazilImplementation of hepatitis B vaccine in high-risk young adults with waning immunityResponse to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in KoreaImmune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis
P2860
Q30152118-A9107E32-4037-4FDC-B851-0894AB1F842CQ30244568-8978A89B-FE9B-4D34-A778-2B0F8046E958Q36140481-0F0A5AED-EEA7-4858-9F87-F3DBF22CD872Q37023727-F6DFC256-AEA9-4D3F-A309-FDF327856C5EQ38634689-7EE6F171-1BBF-4424-BC6A-2F970AF4B613Q38743832-EB584B36-7299-4A42-8775-4CA4D5ADCB63Q38912896-6EAC3069-B270-47AE-B04D-44DFB69DB353Q40060795-BD0A9858-B96D-45ED-BDA5-AC6133671A96Q40373187-523A7B21-3F91-4048-A284-D9BB9E7E1DF0Q40440788-5355CC62-A864-4BEC-A053-5B9D2D8A21E0Q40527467-0A7D969A-3196-457C-BC7E-04409AC23AB0Q41921526-02739024-A6A5-4ABE-A9FF-185D24D754A7Q48103063-D1D8AEFA-AC5F-4A8C-A9E2-D637A7DC2B4DQ50047495-A6D14EA6-2435-469E-961E-0AFD76E80C2BQ50229859-54277D23-0F22-4DA0-9B75-DB3E932ABAE7Q50593538-0D6A3CFC-014D-406C-A2D4-0921ED5C8DCDQ52594315-E9AF777C-63F3-4AAA-8FDC-2C877560690BQ55316446-4C7742FD-0BF5-4CA8-925E-62A973D4B4A2Q56396014-11298A19-0620-4D7D-8FAC-909778F1520CQ57001971-A7DDF7C6-136F-4ABB-BE41-0852525D936AQ57284270-72C1554A-DBC5-4D5E-82D8-202D3F06CAA1Q58721551-1C92F645-A6C3-407F-B174-0424A6FE31A1
P2860
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@ast
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@en
type
label
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@ast
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@en
prefLabel
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@ast
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@en
P2093
P2860
P356
P1476
Antibody Levels and Protection ...... nd Response to a Booster Dose.
@en
P2093
Brian J McMahon
Carolyn Zanis
Debby Hurlburt
Gail Thompson
Karen Rudolph
Lisa Bulkow
Lisa Townshend-Bulson
Michael G Bruce
Michele Toomey
P2860
P356
10.1093/INFDIS/JIV748
P407
P577
2016-01-21T00:00:00Z